by Lea Rebholz | Aug 10, 2023 | Blogbeitrag (EN), C1
74 million people in Germany, and thus almost 90 % of the population, have statutory health insurance. So when it comes to the question of how to bring a new, innovative product to market, medtech start-ups often find a quick answer in the statutory health insurers...
by Lea Rebholz | Jun 5, 2023 | C1, Interviews (EN)
With 11 years of experience in the top management of established healthcare companies, including B. Braun, as well as over 20 years as an independent consultant with an internationally represented team, Dr. Claus Michelfelder can truly be called an expert for the...
by Lea Rebholz | Aug 23, 2022 | C1, Interviews (EN)
Not every product that was originally intended as a medical device actually is one: it depends on the intended use! That’s what the startup tinus learned at the 4C Accelerator. Since their product has no medical purpose, is non-invasive and poses no risk to the...
Recent Comments